Login / Signup

CD24 blockade promotes anti-tumor immunity in oral squamous cell carcinoma.

Ke-Long ZouZhou LanHao CuiYu-Yue ZhaoWei-Ming WangGuang-Tao Yu
Published in: Oral diseases (2022)
Targeting CD24 could enhance anti-tumor immune response by inhibiting TAMs.
Keyphrases
  • immune response
  • signaling pathway
  • cancer therapy
  • dendritic cells
  • inflammatory response